tailieunhanh - Diagnosis and clinical management in prostate cancer: Part 2

(BQ) Continued part 1, part 2 of the document Diagnosis and clinical management in prostate cancer has contents: Radiation therapy in the management of prostate cancer, novel therapies for localized prostate cancer, diagnosis and management of metastatic prostate cancer, end of life care in prostate cancer,. and other contents. Invite you to refer. | CHAPTER 9 Radiation Therapy in the Management of Prostate Cancer J. Conibear1 and . Hoskin2 1Mount Vernon Cancer Centre Middlesex UK 2University College London Mount Vernon Cancer Centre Northwood UK Introduction Radiation is one of the principal treatment modalities for prostate cancer 1 2 . Since the early twentieth century radiation has been used to treat all stages of the disease. In 1904 Armand and Leon Imbert were the first clinicians to report on the successful use of X-ray therapy to treat an advanced prostate cancer 3 . In 1908 both Minet and Desnos used radium-containing catheters to deliver an early form of brachytherapy and in 1923 Waters and Pierson used deep X-rays to treat a prostate cancer bony metastasis 4-7 . Over the past century radiation therapy for prostate cancer has undergone dramatic changes as a result of advances in radiobiology physics and computer technology. Now in the twenty-first century practitioners of prostate cancer radiation therapy can tailor their treatments to the stage and needs of the patient. External beam radiotherapy The first attempts to use X-rays to treat prostate cancer relied upon low-energy beams. Compared to modern megavoltage X-rays they lacked the comparative depth of penetrance and consequently led to high-radiation doses at the patient s skin surface. This meant early prostate cancer patients suffered significant acute skin toxicity and an increased risk of radiation-induced skin cancers. Due to these early drawbacks the use of low-energy beams to treat localized prostate cancer remained relatively low in the first half of the twentieth century. Prostate Cancer Diagnosis and Clinical Management First Edition. Edited by Ashutosh K. Tewari Peter Whelan and John D. Graham. 2014 John Wiley Sons Ltd. Published 2014 by John Wiley Sons Ltd. 170 Radiation Therapy in the Management of Prostate Cancer 171 Prior to World War II important discoveries were made in radiation science that led to new developments in .

• Y khoa - Dược
• Radiation therapy
• Prostate cancer
• Clinical management
• Prostate cancer
• Metastatic prostate cancer
• Localized prostate cancer
• BMC Cancer
• Decision making
• Radiation therapy centres
• Lung cancer
• Radiation induced lung toxicity
• Functional imaging
• Intraoperative radiotherapy
• Pancreatic cancer
• Neoadjuvant therapy
• Locally advanced pancreatic cancer
• Stereotactic body radiation therapy
• Breast conserving surgery
• Overall survival
• Adjuvant radiation therapy
• Elderly breast
• Anal canal
• Squamous cell carcinoma
• Intensity modulated radiation therapy
• Conformal therapy
• Volumetric modulated arc therapy
• Lymphocyte sparing
• Conventionally fractionated
• Single center phase I/II trial
• Recurrent retroperitoneal sarcomas
• Retroperitoneal soft tissue sarcoma
• Intraoperative radiation therapy
• Hepatocellular carcinoma
• Local control rate
• Paranasal sinus
• Nasal cavity cancer
• Proton beam therapy
• Cost effectiveness analysis
• Intensity modulated proton radiation therapy
• Intensity modulated photon radiation therapy
• Endometrial cancer
• Helical tomotherapy
• Volumetric modulated arc therapy
• Upper third esophageal cancer
• Concurrent chemoradiotherapy
• Intensitymodulated radiation
• Esophageal cancer patients
• Radiation induced injury
• Biologically effective dose
• Adrenal gland metastases
• Radiation oncology
• Tumor diseases
• Additional therapeutic
• Báo cáo khoa học
• báo cáo y học
• công trình nghiên cứu về y học
• tài liệu về y học
• cách trình bày báo cáo
• Stereotactic ablative therapy
• Established noninvasive treatment
• Selective internal radiation therapy
• Transarterial chemoembolization
• Tumor infiltrating lymphocytes
• Locoregional therapy
• Post operative
• Non small cell lung cancer
• Standard therapy
• Advanced hepatocellular carcinoma
• Liver cancer
• Randomized controlled trial
• Systemic therapy
• Borderline resectable pancreatic cancer
• Anatomically widely spread
• Primary therapy
• Primary androgen deprivation therapy
• Radical prostatectomy
• Risk classification
• Active surveillance
• 3D conformal radiotherapy
• Progression free survival
• Risk classification
• DNA damage
• Radiation sensitivity
• Extracellular matrix